We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+1.26%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$17.3B
AUM Growth
+$1.23B
(+7.7%)
Cap. Flow
+$1.39B
Cap. Flow
% of AUM
8.03%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
799
New
24
Increased
502
Reduced
229
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eldorado Gold
EGO
|
+$92.2M |
| 2 |
AngloGold Ashanti
AU
|
+$67.3M |
| 3 |
AUY
Yamana Gold, Inc.
AUY
|
+$66.5M |
| 4 |
Gilead Sciences
GILD
|
+$66.5M |
| 5 |
SUNE
SUNEDISON, INC COM
SUNE
|
+$64.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RIOM
RIO ALTO MNG LTD NEW COM SHS (CANADA)
RIOM
|
+$101M |
| 2 |
NOV
NOV
|
+$99.9M |
| 3 |
B
Barrick Mining
B
|
+$56.7M |
| 4 |
AGN
Allergan plc
AGN
|
+$52M |
| 5 |
Newmont
NEM
|
+$49.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 41.54% |
| 2 | Energy | 25.34% |
| 3 | Healthcare | 8.32% |
| 4 | Industrials | 4.11% |
| 5 | Technology | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
151
Novo Nordisk
NVO
$216B
| $18.9M | 0.11% |
709,794
-5,084
| -0.7% | -$117K |
|
|
BRCM
152
DELISTED
BROADCOM CORP CL-A
BRCM
| $18.6M | 0.11% |
428,732
+4,693
| +1% | +$205K |
|
153
Applied Materials
AMAT
$426B
| $18.1M | 0.1% |
800,640
+38,281
| +5% | +$917K |
|
154
Skyworks Solutions
SWKS
$9.06B
| $17.8M | 0.1% |
181,115
-4,882
| -3% | -$417K |
|
|
WBA
155
DELISTED
Walgreens Boots Alliance
WBA
| $17.7M | 0.1% |
209,138
+90,173
| +76% | +$7.18M |
|
|
ARMH
156
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $17.6M | 0.1% |
356,387
-41,148
| -10% | -$2.05M |
|
157
Idexx Laboratories
IDXX
$42.9B
| $17.3M | 0.1% |
223,924
+1,280
| +0.6% | +$99.6K |
|
|
QGENF
158
DELISTED
QIAGEN NV
QGENF
| $17.2M | 0.1% |
684,357
-85,613
| -11% | -$2.16M |
|
159
Sanofi
SNY
$104B
| $17.2M | 0.1% |
347,940
-8,874
| -2% | -$424K |
|
|
SVM
160
Silvercorp Metals
SVM
$2.13B
| $17.2M | 0.1% |
14,548,602
+1,922,890
| +15% | +$2.56M |
|
161
McEwen Inc
MUX
$1.03B
| $17M | 0.1% |
1,669,024
+306,698
| +23% | +$3.43M |
|
162
Analog Devices
ADI
$181B
| $16.8M | 0.1% |
267,440
-14,993
| -5% | -$850K |
|
163
Costco
COST
$415B
| $16.8M | 0.1% |
110,680
+52,147
| +89% | +$7.65M |
|
164
Cencora
COR
$60.3B
| $16.6M | 0.1% |
146,006
+100,451
| +221% | +$10.1M |
|
|
AGN
165
DELISTED
Allergan plc
AGN
| $16.6M | 0.1% |
55,756
-182,543
| -77% | -$52M |
|
166
GSK
GSK
$103B
| $16.5M | 0.1% |
286,282
-14,726
| -5% | -$844K |
|
|
DO
167
DELISTED
Diamond Offshore Drilling
DO
| $16.5M | 0.1% |
616,033
+160,153
| +35% | +$4.99M |
|
|
EXK
168
Endeavour Silver
EXK
$2.32B
| $16.5M | 0.1% |
8,682,046
+1,147,505
| +15% | +$2.68M |
|
169
Lowe's Companies
LOW
$116B
| $16.4M | 0.09% |
220,784
+95,607
| +76% | +$6.85M |
|
170
Eli Lilly
LLY
$1.07T
| $15.8M | 0.09% |
217,727
+8,832
| +4% | +$629K |
|
171
AGNC Investment
AGNC
$12.3B
| $15.7M | 0.09% |
735,225
+123,703
| +20% | +$2.68M |
|
172
AstraZeneca
AZN
$263B
| $15.6M | 0.09% |
228,056
+28,040
| +14% | +$1.95M |
|
173
Ionis Pharmaceuticals
IONS
$9.35B
| $15.5M | 0.09% |
243,365
-3,503
| -1% | -$238K |
|
174
TJX Companies
TJX
$170B
| $15.4M | 0.09% |
438,518
+208,336
| +91% | +$7.09M |
|
175
Target
TGT
$62.1B
| $15.3M | 0.09% |
186,669
+86,199
| +86% | +$6.66M |
|
Similar funds
DAM
VanEck Associates's Q1 2015 Portfolio in Review
As of Q1 2015, VanEck Associates held 799 positions worth $17.3B, up 7.7% from $16.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
VanEck Associates deployed $1.39B of net new capital in Q1 2015, opening 24 new positions and adding to 502 existing holdings. Its largest new stake was Philip Morris: 575,677 shares worth $43.4M.
By sector, the portfolio is most concentrated in Materials at 42% of assets, down from 44% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was RIO ALTO MNG LTD NEW COM SHS (CANADA), an estimated $101M trimmed.
- VanEck Associates's largest Q1 2015 buy was Philip Morris: 575,677 shares worth $43.4M.
- VanEck Associates added most to Eldorado Gold in Q1 2015, an estimated $92.2M increase.
- VanEck Associates's biggest Q1 2015 reduction was RIO ALTO MNG LTD NEW COM SHS (CANADA), cutting an estimated $101M.
- VanEck Associates fully exited eBay in Q1 2015, selling an estimated $48.1M.
- VanEck Associates's ten largest holdings make up 25% of its $17.3B portfolio in Q1 2015.
- VanEck Associates opened 24 new positions and closed 30 in Q1 2015.
- VanEck Associates's portfolio value rose 7.7% quarter-over-quarter to $17.3B.
Based on VanEck Associates's 13F filing for Q1 2015, filed 14 May 2015.